by Technology Networks –
In a first-in-human Phase 1/2a clinical trial, adult stem cells improved vision in patients with macular degeneration.
In the United States, age-related macular degeneration is a leading cause of irreversible vision loss in people who are 60 and older.
It affects the central portion of the retina, called the macula. This region is packed with cells responsible for high-resolution color vision.
About 20 million U.S. adults are living with some form of AMD. Although they cannot see objects that are directly in front of them, their peripheral vision is unaffected.
